KCM
SLXP

Kingdon Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Kingdon Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-179,600
Closed -$20.6M – 212
2014
Q4 		$20.6M Sell
179,600
-12,100
-6% -$1.47M 1.1% 36
2014
Q3 		$29.9M Buy
191,700
+166,700
+667% +$24.2M 1.93% 12
2014
Q2 		$3.08M Buy
+25,000
New +$2.76M 0.16% 157
2014
Q1 		– Sell
-80,400
Closed -$7.23M – 244
2013
Q4 		$7.23M Sell
80,400
-18,300
-19% -$1.46M 0.51% 95
2013
Q3 		$6.6M Buy
98,700
+40,000
+68% +$2.76M 0.48% 90
2013
Q2 		$3.88M Buy
+58,700
New +$3.36M 0.34% 116

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $32.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return